Ashley Mcevoy $JNJ SEC Form 4 Insider Trading

Ashley Mcevoy has filed a total of 2 insider trades in $JNJ since 2021. Their most recent trade was a sale of 1,400 shares, made on Nov 30, 2022. Their largest trade was a sale of 71,923 shares, made on Nov 30, 2022. We estimate that they now own 52,037 shares of $JNJ, worth an estimated $7.6 million.

Insider Trading at $JNJ

There have been a total of 347 insider trades reported at $JNJ since 2021, with 1,000 shares purchased and 637,058 shares sold. The most active insider traders in $JNJ stock have been Peter Fasolo, Thibaut Mongon, and William Hait. The most recent trade was a purchase of 1,000 shares reported by MARK A WEINBERGER (None), made on Dec 12, 2024.

$JNJ Executives and Stock Owners with Insider Trades

• Peter Fasolo, Exec VP, Chief HR Officer

• Thibaut Mongon, Exec VP, WW Chair, Consumer

• William Hait, See Remarks

• Kathryn E Wengel, EVP, Chief GSC Officer

• Robert J Decker, Controller, CAO

• Ashley Mcevoy, EVP, WW Chair, MedTech

• Jennifer L Taubert, EVP, WW Chair, Pharmaceuticals

• Joseph J Wolk, Exec VP, CFO

• James D. Swanson, See Remarks

• Kathryn E Wengel, EVP, Chief TO and Risk Officer

• Robert J Decker, VP Corporate Controller

• Vanessa Broadhurst, EVP, Global Corp Affairs

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.